Ertapenem

🧮 Dose calculator

Diabetic foot infection · Regimen source: FDA Ertapenem · 2.2, Table 1

• • Not studied in diabetic foot infection with concomitant osteomyelitis. Infuse over 30 min; no dextrose diluents. FDA Ertapenem · 2.2, Table 1FDA Ertapenem · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ertapenem · 8.1

  “Risk Summary Available data from a small number of post-marketing cases with Ertapenem for injection use in pregnancy are insufficient to inform any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Ertapenem · 8.2

  “Risk Summary Ertapenem is present in human milk (see Data ).”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ertapenem · 8.4

  “Safety and effectiveness of Ertapenem for injection in pediatric patients 3 months to 17 years of age are supported by evidence from adequate and well-controlled trials in adults, pharmacokinetic data in pediatric patients, and additional data from comparator-controlled trials in pediatric patients 3 months to 17 …”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ertapenem · 8.5

  “Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function [see Dosage and Administration (2.2) ].”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.